Abstract
This report examines the market for OTC analgesics last reported by Mintel in December 2004. Despite a slight dip in 2004, market values have risen slightly since then.
As consumers are encouraged to take more responsibility for their health and self-medication increases, the likely areas for growth in over the counter analgesics look set to be the continued development of paediatric formulations, targeted formulations for muscle strains and sports injuries, migraine treatments and premium products packaged for use on the move.
View Cart
